Michael Deininger

2.5k total citations
6 papers, 21 citations indexed

About

Michael Deininger is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Michael Deininger has authored 6 papers receiving a total of 21 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Hematology and 2 papers in Molecular Biology. Recurrent topics in Michael Deininger's work include Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper). Michael Deininger is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper). Michael Deininger collaborates with scholars based in United States, Germany and France. Michael Deininger's co-authors include John M. Goldman, Junia V. Melo, Joanna Góra‐Tybor, Dietger Niederwieser, Sebastian Weiterer, James A. McCloskey, Thorsten Brenner, Srinivas K. Tantravahi, Charles Chuah and Jeffrey T. Yap and has published in prestigious journals such as Blood, British Journal of Haematology and Clinical Lymphoma Myeloma & Leukemia.

In The Last Decade

Michael Deininger

6 papers receiving 21 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Deininger United States	3	14	9	7	5	3	6	21
Maria Creignou Sweden	4	15 1.1×	12 1.3×	4 0.6×	6 1.2×	3 1.0×	12	23
Sari E. Jalkanen Finland	2	14 1.0×	10 1.1×	6 0.9×	6 1.2×	1 0.3×	3	19
Elza Lomaia Russia	3	22 1.6×	21 2.3×	8 1.1×	8 1.6×		14	28
Nguyen Tan Binh Vietnam	4	14 1.0×	15 1.7×	9 1.3×	7 1.4×	2 0.7×	7	24
Hyeoung Joon Kim South Korea	3	18 1.3×	13 1.4×	4 0.6×	6 1.2×	1 0.3×	4	19
Benjamin Carpentier France	4	9 0.6×	11 1.2×	10 1.4×	4 0.8×	7 2.3×	9	28
Longcheng Wang United States	3	6 0.4×	5 0.6×	5 0.7×	8 1.6×	3 1.0×	3	26
Odile Luycx France	2	17 1.2×	14 1.6×	5 0.7×	4 0.8×		2	17
Danielle H. Shin Canada	2	18 1.3×	14 1.6×	11 1.6×	2 0.4×		3	26
Irene Donnini Italy	3	14 1.0×	11 1.2×	7 1.0×		1 0.3×	8	26

Countries citing papers authored by Michael Deininger

Since Specialization

Citations

This map shows the geographic impact of Michael Deininger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Deininger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Deininger more than expected).

Fields of papers citing papers by Michael Deininger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Deininger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Deininger. The network helps show where Michael Deininger may publish in the future.

Co-authorship network of co-authors of Michael Deininger

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Deininger. A scholar is included among the top collaborators of Michael Deininger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Deininger. Michael Deininger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Tantravahi, Srinivas K., et al.. (2024). Long-Term Response to Selinexor in Patients With Myelofibrosis and Refractory or Intolerant to JAK Inhibitors: Follow-Up Results of a Single-Center, Phase II, Investigator-Initiated Trial (IIT). Clinical Lymphoma Myeloma & Leukemia. 24. S207–S207. 1 indexed citations

2.

Deininger, Michael, Jane Apperley, Christopher Arthur, et al.. (2022). CML-047 Post Hoc Analysis of Responses to Ponatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML) by Baseline BCR::ABL1 Level and Baseline Mutation Status in the OPTIC Trial. Clinical Lymphoma Myeloma & Leukemia. 22. S285–S286. 1 indexed citations

3.

Weiterer, Sebastian, Karsten Schmidt, Michael Deininger, et al.. (2016). Komplexe Fokussanierung in der Sepsis. Der Anaesthesist. 65(9). 696–702. 2 indexed citations

4.

Traer, Elie, et al.. (2010). JAK2-Mediated Extrinsic Survival of CML Stem Cells: Exploring the Potential Combination of BCR-ABL and JAK2 Inhibitors In Vivo. Blood. 116(21). 199–199. 2 indexed citations

5.

Deininger, Michael & Dietger Niederwieser. (2002). Molekulare therapie der CML - Eine neue ära in der behandlung maligner erkrankungen. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 97. 3 indexed citations

6.

Góra‐Tybor, Joanna, Michael Deininger, John M. Goldman, & Junia V. Melo. (1998). The susceptibility of Philadelphia chromosome positive cells to FAS‐mediated apoptosis is not linked to the tyrosine kinase activity of BCR‐ABL. British Journal of Haematology. 103(3). 716–720. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact